Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Tirzepatide (Mounjaro) has shown even stronger weight loss results, with an average weight loss of 15-20% in recent trials
However, significant limitations exist in the current evidence: Most human data comes from small studies, with limited randomised controlled trials specifically designed to assess alcohol consumption The mechanisms by which GLP-1 medications might reduce alcohol intake are not fully understood Individual responses vary considerably, and not all patients experience changes in drinking behaviour Long-term effects and safety of using these medications specifically for alcohol reduction remain unknown The MHRA has not approved GLP-1 receptor agonists for alcohol use disorder, and these medications should not be considered a treatment for problematic drinking
If you are pregnant or breastfeeding, please consult your doctor, pharmacist or other healthcare professional before using this product
Furthermore, vitamin C provides an antioxidant boost to neutralize UV damage and reduce the appearance of dark spots
AACR(423), 1994
US$ 28.70
US$ 28.07
US$ 23.68
US$ 24.80
